The importance of Quality by Design (QbD) is being realized gradually, as it is gaining popularity among the generic companies. However, the major hurdle faced by these industries is the lack of common guidelines or format for performing a risk-based assessment of the manufacturing process. This article tries to highlight a possible sequential pathway for performing QbD with the help of a case study. The main focus of this article is on the usage of failure mode and effect analysis (FMEA) as a tool for risk assessment, which helps in the identification of critical process parameters (CPPs) and critical material attributes (CMAs) and later on becomes the unbiased input for the design of experiments (DoE). In this case study, the DoE was helpful in establishing a risk-based relationship between critical quality attributes (CQAs) and CMAs/CPPs. Finally, a control strategy was established for all of the CPPs and CMAs, which in turn gave rise to a robust process during commercialization. It is noteworthy that FMEA was used twice during the QbD: initially to identify the CPPs and CMAs and subsequently after DoE completion to ascertain whether the risk due to CPPs and CMAs had decreased.
Quality
by Design (QbD) is of paramount importance not only for
patient safety but also for the timely and uninterrupted supply of
products at affordable prices into the market. Both of these objectives
can be achieved only through a robust process, and one of the major
obstacles for developing a robust process is the quality of input
materials and reagents used for the manufacture of active pharmaceutical
ingredients (APIs). This article demonstrates the use of QbD methodology
to optimize the quality of input materials and make the process more
consistent, thereby reducing the variation in the quality of API produced.
This article highlights the use of failure mode and effect analysis
(FMEA) for the unbiased identification of critical process parameters
and critical material attributes associated with the manufacturing
of key starting materials, which are later used as input for the design
of experiments (DoE) study that is used for the optimization.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.